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Dengue: Relationships between the severity of
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Viron, Y. Brouste, R. Cesaire
Hospital P Zobda-Quitman, Fort de France, France
Background: In 2010,Martinique experienced a severe DENV-1
and DENV-4 coepidemic involving more than 10% of the popula-
tion. A study was conducted in the Emergency Department (ED)
to investigate the relationships between clinical severity of illness
and virological characteristics.
Methods & Materials: Dengue-like patients admitted within
8 days after the onset of fever were eligible. Data were recorded
at presentation. Final outcome data were collected in all patients.
Dengue cases were conﬁrmed and serotyped by a hemi-nested
RT-PCR. Dengue-speciﬁc antibodies were detected by using IgM
capture, IgG capture, and IgG indirect enzyme linked immunosor-
bent assays. Basedondisease severity and thepatient caremethods,
we distinguished three groups of clinical forms: uncomplicated
forms treated at home with simple monitoring (G1), intermediate
severity forms warranting intravenous rehydration in the ED and
followed-up under ambulatory conditions (G2) and severe forms
including DHF/DSS that most often warranted hospitalization (G3)
Results: The study included 201 patients (107 females, median
age 38 years, range 15-89). DENV-1 was demonstrated in 126
(63%) patients and DENV-4 in 75 (37%). Secondary infections were
recorded more frequently in DENV-4 than in DENV-1 infections
(64.5% versus 50%, respectively, p <0.001). Regarding clinical sever-
ity, G1 included 118 patients (58.7%), G2 included 50 patients
(24.5%) and G3 included 33 patients (16,4%). The distribution of
severe forms was not signiﬁcantly different between serotypes
and between primary and secondary infections. When sampled
between day-1 and -3 of illness, primary infections demonstrated
higher viremias than secondary infections (respectively, median
9.09 log, [IQR 8.01-10.62] and 8.41.log [IQR 7.15-9.47], p <0.01). In
all, DENV-1 infections demonstrated higher viremias than DENV-4
infections (respectively, median 8.56 log [IQR 7.17-9.82] and 7.69
log [IQR 6.17-8.64], p <0.001). Median viremias were 8.60 log (IQR
7.32-9.76) in G1, 7.65 log (IQR 6.78-8.71) in G2 and 7.47 log (IQR
5.36-8.79) in G3 (p=0.003). However, the patients with severe and
intermediate severity forms were admitted and sampled later than
patients with uncomplicated forms (respectively, median day 5
[IQR 4-5], day 5 [4-6], day 3 [2-4], p <0.001).
Conclusion: During the 2010 epidemic inMartinique, DENV-
1 and primary infections demonstrated higher viremias. Clinical
severity was independent from serotypes and immune status.
http://dx.doi.org/10.1016/j.ijid.2014.03.1095
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Epidemiological features of sindbis fever in
South Africa
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Background: Sindbis virus (SINV), a mosquito-borne
alphavirus, is a cause of outbreaks of febrile arthralgia in Scandi-
navia, Russia and South Africa. Sindbis virus circulates in several
bird species, but is also occasionally transmitted to humans. The
occurance of SINV in South Africa has been known since the 1970s
but the true burden of the disease is not know due to inadequate
surveillance.
Methods & Materials: A retrospective study was conducted
using data from submissions for laboratory investigation for
patients with suspected arboviral disease from 2006 to 2010 in
South Africa. Data (including count, demographic information,
geographic origin and clinical presentation) were collected from
test requisition forms and questionnaires and statistical analysis
performedusingEpiInfo software. The laboratory criteria for conﬁr-
mation of SINV infection includes detection of SINV RNA by RT-PCR
or virus isolation. The detection of anti-SINV IgM antibodies by
ELISA was considered to be highly suggestive of recent infection
with SINV.
Results: Between 2006 and 2010, a total of 3 631 specimens
for patients with suspected arbovirus disease were submitted for
laboratory investigation. During this period a total of 229 speci-
mens tested positive for anti-SINV IgM antibodies. The detection
rate for IgM antibodies increased nearly 10-fold during 2010 (from
average of 1.3% to 10%). In the 2010, the majority of cases were
reported from the semi-arid regions of South Africa, forming part
of the Northern Cape and Free State Provinces. The number of cases
peaked during the late summer and early autumn months. Sindbis
fever was more common in males and rate of infection increased
linearly with age. Typical symptoms included muscle pain, fever,
joint pain, headache and fatigue.
Conclusion: The study provided an update of Sindbis fever in
humans in South Africa. There was a marked increase of cases dur-
ing 2010,which coincidedwith the outbreak of Rift Valley fever and
West Nile fever at the same time. The need for systematic surveil-
lance for Sindbis fever in order to better understand the public
health burden of the disease is highlighted.
http://dx.doi.org/10.1016/j.ijid.2014.03.1096
